Flotillin: A Promising Biomarker for Alzheimer’s Disease

Flotillin: A Promising Biomarker for Alzheimer’s Disease

Alzheimer’s disease (AD) is characterized by the accumulation of beta amyloid (Aβ) in extracellular senile plaques and intracellular neurofibrillary tangles (NFTs) mainly consisting of tau protein. Although the exact etiology of the disease remains elusive, accumulating evidence h...

Full description

Bibliographic Details
Main Authors:	Efthalia Angelopoulou, Yam Nath Paudel, Mohd. Farooq Shaikh, Christina Piperi
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Journal of Personalized Medicine
Subjects:	flotillin alzheimer’s disease biomarker exosomes beta-amyloid tau
Online Access:	https://www.mdpi.com/2075-4426/10/2/20

Similar Items

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
by: Hui‐Fu Wang, et al.
Published: (2020-01-01)

Cholesterinabhängige subzelluläre Lokalisation von Flotillin
by: Weiss, Sievert
Published: (2013)

Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers
by: Chunyan Liao, et al.
Published: (2021-08-01)

Case Report: Anti-flotillin 1/2 Autoantibody-Associated Atypical Dementia
by: Niels Hansen, et al.
Published: (2021-06-01)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
by: Franc Llorens, et al.
Published: (2017-09-01)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
by: Giovanni Bellomo, et al.
Published: (2021-03-01)

Research advances on flotillins
by: Li Li, et al.
Published: (2011-10-01)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
by: Zvěřová M
Published: (2018-07-01)

Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics
by: Aaron eRitter, et al.
Published: (2015-08-01)

Etude du rôle de la surexpression des flotillines dans l'invasion cellulaire
by: Planchon, Damien
Published: (2017)

Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer’s Disease Progression
by: Eunjoo Nam, et al.
Published: (2020-07-01)

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
by: Donovan A. McGrowder, et al.
Published: (2021-02-01)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
by: Meng-Shan Tan, et al.
Published: (2020-05-01)

Expanding the repertoire of biomarkers for Alzheimer’s disease: targeted and non-targeted approaches.
by: Douglas eGalasko
Published: (2015-12-01)

Infection by Anaplasma phagocytophilum Requires Recruitment of Low-Density Lipoprotein Cholesterol by Flotillins
by: Qingming Xiong, et al.
Published: (2019-03-01)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
by: Ricardo F. Allegri, et al.
Published: (2020-01-01)

Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease
by: Francheska Delgado-Peraza, et al.
Published: (2021-04-01)

Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
by: Md Shahjalal Hossain Khan, et al.
Published: (2020-05-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

Endocytic Trafficking of Membrane-Bound Cargo: A Flotillin Point of View
by: Melanie Meister, et al.
Published: (2014-07-01)

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
by: Syed Haris Omar, et al.
Published: (2020-07-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Etude de la dynamique de tau dans le compartiment synaptique dans un contexte physiologique et pathologique exemple de la maladie d'Alzheimer
by: Frandemiche, Marie-Lise
Published: (2013)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
by: Nicholas J. Ashton, et al.
Published: (2019-12-01)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
by: Yam Nath Paudel, et al.
Published: (2020-06-01)

Flotillins: At the Intersection of Protein <i>S-</i>Palmitoylation and Lipid-Mediated Signaling
by: Katarzyna Kwiatkowska, et al.
Published: (2020-03-01)

Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer’s Disease Patients, Possible Biomarkers for Early Diagnosis
by: Alfonso Grimaldi, et al.
Published: (2019-09-01)

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
by: Cristina d’Abramo, et al.
Published: (2020-09-01)

Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
by: Jennifer Ngolab, et al.
Published: (2017-06-01)

Advances and considerations in AD tau-targeted immunotherapy
by: Alice Bittar, et al.
Published: (2020-02-01)

Meta-Review of CSF core biomarkers in Alzheimer’s disease: the state-of-the-art after the new revised diagnostic criteria
by: Daniel eFerreira, et al.
Published: (2014-03-01)

Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
by: Lutz Frölich, et al.
Published: (2017-10-01)

Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2019-12-01)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
by: Rachel L. Henson, et al.
Published: (2020-01-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Diagnostic biomarkers in Alzheimer’s disease
by: Emerlee Andersen, et al.
Published: (2021-12-01)

Inhibiteurs et modèles moléculaires de fibres amyloïdes ° et tau impliquées dans la maladie d'Alzheimer : conception, synthèse et caractérisation
by: Dufour, Emilie
Published: (2013)

Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
by: Robert A. Whittington, et al.
Published: (2017-11-01)